Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share

Go back to Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 5.04 --0 (-0%)
Previous Close $5.04    52 Week High $1.44 
Open $5.04    52 Week Low $0.06 
Day High $5.04    P/E N/A 
Day Low $5.04    EPS $-1.24 
Volume 1,584